11486160

Source:http://linkedlifedata.com/resource/pubmed/id/11486160

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001175, umls-concept:C0019682, umls-concept:C0019699, umls-concept:C0041714, umls-concept:C0162696, umls-concept:C0449435, umls-concept:C1705426
pubmed:issue	4
pubmed:dateCreated	2001-8-3
pubmed:abstractText	Changing evidentiary standards and partial shift of the investigational phase of drug approval process to the postmarketing phase.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9441347
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1075-2765
pubmed:author	pubmed-author:MeinertCC, pubmed-author:ShaferCC, pubmed-author:TonasciaSS, pubmed-author:UnalpAA
pubmed:issnType	Print
pubmed:volume	7
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	257-63
pubmed:meshHeading	pubmed-meshheading:11486160-Acquired Immunodeficiency Syndrome, pubmed-meshheading:11486160-Anti-HIV Agents, pubmed-meshheading:11486160-Drug Approval, pubmed-meshheading:11486160-Follow-Up Studies, pubmed-meshheading:11486160-HIV Infections, pubmed-meshheading:11486160-Information Services, pubmed-meshheading:11486160-Product Surveillance, Postmarketing, pubmed-meshheading:11486160-United States, pubmed-meshheading:11486160-United States Food and Drug Administration
pubmed:year	2000
pubmed:articleTitle	FDA censoring of manufacturers' postmarketing commitments in HIV/AIDS drug approval letters.
pubmed:affiliation	Center for Clinical Trials, Department of Epidemiology, The Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland 21205, USA. aunalp@jhsph.edu
pubmed:publicationType	Journal Article